Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque

Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease

(2009) Joaquin De Haro et al.   HEART AND VESSELS

Presence of irregularity in region between −1115 and −784 nt in P1 promoter of Insulin-Like Growth Factor-1 gene may indicate beneficial effect on coronary arteries in a group of patients with stable angina: preliminary data

(2009) Pawel Burchardt et al.   HEART AND VESSELS

Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growthin vivo

(2009) Sunitha Ramachandra et al.   JOURNAL OF GENE MEDICINE

Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis

(2009) Judith C Sluimer et al.   JOURNAL OF PATHOLOGY

Thin-Walled Microvessels in Human Coronary Atherosclerotic Plaques Show Incomplete Endothelial Junctions

(2009) Judith C. Sluimer et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Atherosclerotic and Thrombogenic Neointima Formed Over Sirolimus Drug-Eluting Stent

(2009) Tomoaki Higo et al.   JACC-Cardiovascular Imaging

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis

(2008) Fina Lovren et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Atherosclerotic plaque development and instability: A dual role for VEGF

(2008) Pieter W. Holm et al.   ANNALS OF MEDICINE

Modulation of Angiogenesis by a Tetrameric Tripeptide That Antagonizes Vascular Endothelial Growth Factor Receptor 1

(2008) Salvatore Ponticelli et al.   JOURNAL OF BIOLOGICAL CHEMISTRY